Skip to content
★ Sign in to follow
Cresco Labs Inc. logo

Cresco Labs Inc. Stock: price and insider trades · Canada

CA·Mcap CA$340.6MHealth Care
Insider Decl.
458
Thresholds
n/a
Buy Volume
€798,998
36 ops. · all time
Sell Volume
€61M
194 ops. · all time

Who traded when

BuySale
Gregory Randolph Butler1 buy67 sales
Robert Malcom Sampson10 sales
Zachary Austen Marburger1 buy7 sales
John Patrick Schetz7 sales
Randy Dean Podolsky2 buys
Gerald Francis Corcoran1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,604 of 26,897 companies
30.4
score / 100
Value
31
Quality
30
FCF yld12%
Earn yld-46%
EV/EBITDA43.1x
ROE-36%
Gross mgn49%
Net mgn-21%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CA$0.92
Analyst consensus
4 analysts
1.17/5
CA$2.30Target CA$2.54(+176%)CA$2.75
Income statement
RevenueCA$655.8M
Gross profitCA$324.6M49% margin
EBITDACA$20.3M3% margin
Net income-CA$135.4M-15.5% margin
Valuation
PER (forward)-23.0x
P/Book0.7x
Beta1.81
Balance sheet & cash
Market capCA$340.6M
Total debtCA$584.2M
Free Cash FlowCA$34.7M
Debt / Equity225%
Profitability & ownership
ROE-36.1%
ROA3.0%
% insiders2.2%
% institutions3.4%
Last declaration on 21 September 2026
Declarations458 total
  • ◇
    5 - Senior Officer of IssuerExecutives
    17,373 CAD16SEDI
    23,799 shares@ CA$0.730.0055% mcap8.8% of flowSubordinate Voting SharesTSXSEDI:4780115
  • ◇
    5 - Senior Officer of IssuerExecutives
    0SEDI
    33,333 sharesRestricted Stock UnitsTSXSEDI:4780114
  • ◇
    5 - Senior Officer of IssuerExecutives
    21,504 CAD23SEDI
    29,457 shares@ CA$0.730.0068% mcap100.0% of flowSubordinate Voting SharesTSXSEDI:4780113
  • ◇
    5 - Senior Officer of IssuerExecutives
    0SEDI
    41,666 sharesRestricted Stock UnitsTSXSEDI:4780112
  • ◇
    5 - Senior Officer of IssuerExecutives
    84,708 CAD22SEDI
    116,039 shares@ CA$0.730.027% mcap15.6% of flowSubordinate Voting SharesTSXSEDI:4780107
  • ◇
    5 - Senior Officer of IssuerExecutives
    0SEDI
    208,332 sharesRestricted Stock UnitsTSXSEDI:4780105
  • ◇
    4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
    852,523 CAD32SEDI
    1,167,840 shares@ CA$0.730.27% mcap78.6% of flowSubordinate Voting SharesTSXSEDI:4780104
  • ◇
    4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
    0SEDI
    2,096,665 sharesRestricted Stock UnitsTSXSEDI:4780103
  • ◇
    4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives
    0SEDI
    2,096,665 sharesRestricted Stock UnitsTSXSEDI:4780046
  • ▼
    5 - Senior Officer of IssuerExecutives
    21,600 CAD16SEDI
    30,000 shares@ CA$0.720.0068% mcap11.0% of flowSubordinate Voting SharesTSXSEDI:4779569
  • ▼
    5 - Senior Officer of IssuerExecutives
    7,300 CAD15SEDI
    10,000 shares@ CA$0.730.0023% mcap3.7% of flowSubordinate Voting SharesTSXSEDI:4779568
  • ▼
    5 - Senior Officer of IssuerExecutives
    7,231 CAD15SEDI
    10,000 shares@ CA$0.72310.0023% mcap3.7% of flowSubordinate Voting SharesTSXSEDI:4779566
  • ▼
    5 - Senior Officer of IssuerExecutives
    7,174 CAD15SEDI
    10,000 shares@ CA$0.71740.0023% mcap3.6% of flowSubordinate Voting SharesTSXSEDI:4779565
  • ▼
    5 - Senior Officer of IssuerExecutives
    7,172 CAD15SEDI
    10,000 shares@ CA$0.71720.0023% mcap3.6% of flowSubordinate Voting SharesTSXSEDI:4779564
  • ▼
    5 - Senior Officer of IssuerExecutives
    7,171 CAD15SEDI
    10,000 shares@ CA$0.71710.0023% mcap3.6% of flowSubordinate Voting SharesTSXSEDI:4779563
  • ▼
    5 - Senior Officer of IssuerExecutives
    2,160 CAD15SEDI
    3,000 shares@ CA$0.720.0007% mcap1.1% of flowSubordinate Voting SharesTSXSEDI:4779562
  • ▼
    5 - Senior Officer of IssuerExecutives
    3,650 CAD17SEDI
    5,000 shares@ CA$0.730.0012% mcap0.7% of flowSubordinate Voting SharesTSXSEDI:4779561
  • ▼
    5 - Senior Officer of IssuerExecutives
    6,883 CAD17SEDI
    9,240 shares@ CA$0.74490.0022% mcap1.3% of flowSubordinate Voting SharesTSXSEDI:4779560
  • ▼
    5 - Senior Officer of IssuerExecutives
    7,450 CAD17SEDI
    10,000 shares@ CA$0.7450.0024% mcap1.4% of flowSubordinate Voting SharesTSXSEDI:4777942
  • ▼
    5 - Senior Officer of IssuerExecutives
    3,650 CAD17SEDI
    5,000 shares@ CA$0.730.0012% mcap0.7% of flowSubordinate Voting SharesTSXSEDI:4777941
  • ▼
    5 - Senior Officer of IssuerExecutives
    3,650 CAD17SEDI
    5,000 shares@ CA$0.730.0012% mcap0.5% of flowSubordinate Voting SharesTSXSEDI:4777393
  • ▼
    5 - Senior Officer of IssuerExecutives
    3,740 CAD17SEDI
    5,000 shares@ CA$0.7480.0012% mcap0.5% of flowSubordinate Voting SharesTSXSEDI:4776942
  • ▲
    5 - Senior Officer of IssuerExecutives
    3,750 CAD0SEDI
    5,000 shares@ CA$0.750.0012% mcap0.5% of flowSubordinate Voting SharesTSXSEDI:4776941
    Canonical exit: 8 Dec 2026 (T+90)
  • ▼
    5 - Senior Officer of IssuerExecutives
    3,726 CAD15SEDI
    5,000 shares@ CA$0.74510.0012% mcap0.5% of flowSubordinate Voting SharesTSXSEDI:4776940
  • ▼
    5 - Senior Officer of IssuerExecutives
    3,900 CAD15SEDI
    5,000 shares@ CA$0.780.0013% mcap0.5% of flowSubordinate Voting SharesTSXSEDI:4775811

25 of 458 declarations

About Cresco Labs Inc.

Cresco Labs Inc. has 120 sales worth EUR 27,128,828 (median EUR 22,558) against 30 purchases worth EUR 729,054, or 20% purchases among open-market trades. The three largest sales date from 2020 and 2021: EUR 2,854,829 for Dominic Anthony Sergi, a 10% security holder, on July 26, 2021; EUR 2,493,173 for Joseph Stevens Caltabiano, also a 10% holder, on June 1, 2020; EUR 1,471,760 for Marc Lustig, a director, on August 16, 2021.

The largest purchases are by Dennis Martin Olis, a senior officer (EUR 75,600 on May 24, 2022 and EUR 74,631 on August 17, 2023), and John Robert Walter, a director (EUR 68,652 on October 3, 2019). From September 17, 2019 to October 3, 2019, 4 insiders bought EUR 220,190.

Read moreShow less

The Canadian company, classed under health care and with a market capitalisation of CAD 303.6 million, has 329 filings from 21 filers between December 10, 2018 and September 21, 2026. The years 2024 (88) and 2025 (80) are the busiest; the last twelve months hold 90 filings including 70 sales and 2 purchases. Gregory Randolph Butler, a senior officer, signed 57 filings including 48 sales. For 28 purchases, the stored 90-day median result is -13.8%, with 25% of results positive (recorded past, not a forecast).